Formula1.jpg (Formula1)
Dipyridamole Injection
Product Images NDC 0404-9852
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Dipyridamole (NDC 0404-9852). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Henry Schein, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image1.jpg (Image1)
This is a list of drug-related adverse events and the percentage of their incidences for each event. The adverse reactions are chest pain/angina pectoris (197%), headache (12.2%), dizziness (118%), electrocardiographic abnormalities/ST-T changes (75%), extrasystoles (52%), hypotension (46%), nausea (46%), flushing (34%), electrocardiographic abnormalities/tachycardia (32%), dyspnea (26%), pain unspecified (26%), blood pressure lability (16%), hypertension (15%), paresthesia (13%), and fatigue (12%).*
Label1.jpg (Label1)
DIPYRIDAMOLE is a medication available in a 50mg/10ml solution for intravenous use only in myocardial imaging. It is a 5-month expiry injection, diluted before use, and must be kept away from children. The medication has to be used immediately after opening the single-dose vial because the unused portion needs to be discarded. The drug must also be sheltered from light and not be subjected to freezing temperatures. The manufacturer is Hikma Pharmaceuticals USA Inc. and the product is packaged by Henry Schein, Inc. with a lot number XOOKKXKX and item number 2580446. No prescribing information is available.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
